Pressure is mounting on Capitol Hill to reveal the financial relationships among doctors, drug companies and devicemakers through the Physician Payments Sunshine Act.
Six states already have enacted payment-disclosure laws or bans on gifts to doctors. Meanwhile, more medical centers are restricting doctors’ and students’ interactions with industry, as calls grow for medical societies and educators to turn down drugmakers’ dollars.
But now some doctors and physician organizations say the push to police financial relationships with industry has gone too far.
The whole shebang.